TGM2 and hereditary sensory and autonomic neuropathy: TGM2_v2 was several folds higher both in low-grade (Grade 1–2) and Grade 3 differentiated tumours compared with that in CIP (Fig. 5B), suggesting that TG2 may be a marker of malignancy.